AK
Andrew I Koven
President & Chief Business Off

Andrew I Koven insider trades: Aralez Pharmaceuticals (ARLZ) stock buys and sales

President & Chief Business Off, Aralez Pharmaceuticals Last trade Jun 4, 2018 51 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2005
10
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Andrew reports to the SEC

and 4 more companies

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 4, 2018ARLZ↓ Sell$59K
May 14, 2018ARLZ↓ Sell$7K
Mar 19, 2018ARLZ↓ Sell$17K
Jun 5, 2017ARLZ↓ Sell$207K
Mar 20, 2017ARLZ↓ Sell$19K
Mar 15, 2017ARLZ↑ Buy$51K
May 12, 2016ARLZ↑ Buy$249K
Nov 21, 2014AUXL↓ Sell$4.7M
Jul 25, 2005KOSP↓ Sell$706K
May 9, 2005KOSP↓ Sell$1.1M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Andrew I Koven's insider trades

Andrew I Koven is President & Chief Business Off at Aralez Pharmaceuticals (ARLZ). Since May 9, 2005, Andrew has reported 2 open-market purchases worth $300K and 8 sales worth $6.8M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (32 filings), shares withheld for taxes (6 filings), other transactions (5 filings), shares returned to the company (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARLZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.